Figure 3
From: Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients
Clinical outcomes by cytogenetic group. Overall survival (OS) and relapse-free survival (RFS) were both found to be statistically significant (P < 0.5) in child B-cell lymphoblastic leukemia/lymphoma (B-ALL). RFS was statistically significant in adult B-ALL. Child B-ALL were classified into good cytogenetic (Gcyto, n = 26), intermediate cytogenetic (Icyto, n = 26), and high cytogenetic risk (Hcyto, n = 6) groups. Adult B-ALL were classified into Gcyto (n = 2), Icyto (n = 9), and Hcyto (n = 12) groups.
